News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center
Logo of MD Anderson Cancer Center from X
Oct 24, 2023, 13:44

MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center

Quoting

“MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone.

“These findings showcase, for the first time, the potential of combining immunotherapy with a PARP inhibitor to deliver significant clinical improvements for these patients,” says lead investigator Shannon Westin.”

For more details click here.
cancer Endometrial cancer Headlines MD Anderson Cancer Center OncoDaily Oncology Shannon Westin
Special Coverage
Voices
Aug 21, 2025, 23:33
Ohio State Launches Groundbreaking First-in-Human Cancer Drug Trial
Societies
Aug 21, 2025, 23:08
Empowering Cancer Survivors Through the Believe In You Program - Sylvester Comprehensive Cancer Center
Insight
Aug 21, 2025, 20:26
Kevin Harrington Looks Forward to CONCORDE Study Results on DNA Damage Inhibitors and Radiotherapy
Voices
Aug 21, 2025, 20:00
Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding
Voices
Aug 21, 2025, 19:28
Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 15:59
George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer
Voices
Aug 21, 2025, 15:47
European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC
Insight
Aug 21, 2025, 15:37
Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer
Voices
Aug 21, 2025, 15:30
Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore
Voices
Aug 21, 2025, 15:22
Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion
Oncolibrary
Aug 21, 2025, 15:00
Breakthrough Emactuzumab Phase 3 TANGENT Trial in TGCT: SynOx Pharma Reports Enrollment Completed Ahead of Schedule
Voices
Aug 21, 2025, 14:50
Andrea Apolo Highlights the Top 5 Clinical Advances in Bladder Cancer Treatment for 2024